- -

Circulating DNA is a useful prognostic factor in patients with advanced non-small cell lung cancer

RiuNet: Institutional repository of the Polithecnic University of Valencia

Share/Send to

Cited by

Statistics

Circulating DNA is a useful prognostic factor in patients with advanced non-small cell lung cancer

Show full item record

Sirera Pérez, R.; Bremnes, RM.; Cabrera, A.; Jantus Lewintre, E.; Sanmartin, E.; Blasco, A.; Del Pozo, N.... (2011). Circulating DNA is a useful prognostic factor in patients with advanced non-small cell lung cancer. Journal of Thoracic Oncology. 6(2):286-290. doi:10.1097/JTO.0b013e31820189a5

Por favor, use este identificador para citar o enlazar este ítem: http://hdl.handle.net/10251/77269

Files in this item

Item Metadata

Title: Circulating DNA is a useful prognostic factor in patients with advanced non-small cell lung cancer
Author: Sirera Pérez, Rafael Bremnes, Roy M. Cabrera, Andrea Jantus Lewintre, Eloisa Sanmartin, Elena Blasco, Ana del Pozo, Nieves Rosell, Rafael Guijarro, Ricardo Galbis, Jose Sanchez, Jose Javier Camps, Carlos
UPV Unit: Universitat Politècnica de València. Escuela Técnica Superior de Ingeniería Agronómica y del Medio Natural - Escola Tècnica Superior d'Enginyeria Agronòmica i del Medi Natural
Issued date:
Abstract:
Background: Circulating DNA is observed at higher concentrations in patients with lung cancer than in controls. Qualitative and quantitative analysis of circulating DNA is a promising noninvasive tool. Our aim was to ...[+]
Subjects: HTERT , Nonsmall cell lung cancer , NSCLC , Plasma , Prognostic factors , Telomerase , Circulating DNA , Cisplatin , DNA , Docetaxel , Telomerase reverse transcriptase , Unclassified drug , Adult , Advanced cancer , Aged , Article , Blood sampling , Cancer combination chemotherapy , Cancer patient , Cancer staging , Cancer survival , Controlled study , Diagnostic test accuracy study , Enzyme active site , Female , Follow up , Gender and sex , Histology , Human , Lung non small cell cancer , Major clinical study , Male , Multicenter study , Priority journal , Prognosis , Quantitative analysis , Real time polymerase chain reaction , Adenocarcinoma , Aged, 80 and over , Carcinoma, Large Cell , Carcinoma, Non-Small-Cell Lung , Carcinoma, Squamous Cell , DNA, Neoplasm , Follow-Up Studies , Humans , Lung Neoplasms , Middle Aged , Neoplasm Staging , Polymerase Chain Reaction , Prospective Studies , Survival Rate , Tumor Markers, Biological
Copyrigths: Cerrado
Source:
Journal of Thoracic Oncology. (issn: 1556-0864 )
DOI: 10.1097/JTO.0b013e31820189a5
Publisher:
Lippincott, Williams & Wilkins
Publisher version: https://dx.doi.org/10.1097/JTO.0b013e31820189a5
Thanks:
Supported, in part, by the Spanish Society of Medical Oncology (SEOM).
Type: Artículo

This item appears in the following Collection(s)

Show full item record